Bio Medica Laboratories

Name

Bio Medica Laboratories

Legal name

BIO MEDICA LABORATORIES LIMITED

Website

https://biomedica.co.in

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Parenteral injectables
• Pharmaceutical manufacturing
• Veterinary injectables
• Contract manufacturing
• GMP compliant drugs

Headquarters

HQ city

Indore

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Injectables Manufacturing and Sales: Manufactures and sells a wide range of injectable formulations for domestic, international export, and veterinary markets. Revenue generated through product sales to healthcare providers, pharmaceutical distributors, and institutions. The company also offers contract manufacturing services leveraging advanced facilities and expertise.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

BIO MEDICA LABORATORIES LIMITED manufactures and sells a wide range of parenteral (injectable) pharmaceutical formulations for the Indian domestic market, international export markets, and veterinary use. The company operates GMP and GLP-compliant production facilities in Indore, Madhya Pradesh, producing sterile solutions, antibiotics, vitamins, analgesics, and critical care injectables, and additionally offers contract manufacturing, formulation development, and loan licensed manufacturing services to pharmaceutical partners.

Product overview

BIO MEDICA LABORATORIES LIMITED is a prominent parenteral manufacturer in Central India producing a diverse range of injectable formulations. The company operates three core product lines: Injectables for Domestic Market (over 50 formulations including diclofenac sodium, vitamin B-complex, multivitamin, antibiotics, and specialty injectables), Injectables for Export (international-grade formulations including meropenem, vancomycin, ceftriaxone), and Injectables for Veterinary Use (animal health injectables including oxytetracycline, atropine, meloxicam). Supporting services include Contract Manufacturing (custom formulation development and loan licensed manufacturing), Quality Assurance, and Research and Development. All operations adhere to GMP and GLP standards with facilities in Indore, Madhya Pradesh.

Differentiator

Problem solved

Functional benefit

Products and services

• Injectables for Domestic Market Wide range of injectable formulations for the Indian domestic market including diclofenac sodium, vitamin B-complex, multivitamin, antibiotics (amikacin, meropenem, ceftriaxone), and various specialty injectables for pain management, anesthesia, and critical care, targeting hospitals, clinics, and healthcare institutions across India.
• Injectables for Export Injectable formulations exported internationally adhering to global quality standards including omeprazole, artesunate, meropenem, imipenem, co-amoxiclav, ceftriaxone, vancomycin, and other specialty injectables, supplied to international pharmaceutical distributors and healthcare institutions worldwide.
• Injectables for Veterinary Specialized injectable formulations for veterinary use addressing animal health needs including oxytetracycline, atropine sulphate, sulphadimidine, meloxicam, ceftiofur, aceclofenac, and vancomycin, targeted at veterinary clinics, animal healthcare providers, and livestock management operations.
• Contract Manufacturing Services Contract manufacturing services leveraging advanced GMP and GLP-compliant facilities and expertise to produce custom parenteral formulations for pharmaceutical partners, including formulation development and loan licensed manufacturing.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Dr. Reddy's Laboratories: Large Indian generic pharmaceutical manufacturer with a strong injectables franchise (meropenem, vancomycin, ceftriaxone) targeting regulated and emerging markets. Direct overlap with BML's export portfolio molecules, though operating at a global scale with USFDA-approved facilities.
• Cipla: Major Indian pharmaceutical company with a domestic and export injectables portfolio covering antibiotics, oncology, and critical care. Overlaps with BML on commodity injectable generics and contract manufacturing, though at significantly larger scale and broader therapeutic breadth.
• Aurobindo Pharma: One of India's largest generic pharmaceutical manufacturers with a substantial injectable formulations business (AuroMedics) serving US and global markets. Competes with BML in generic injectables but operates at vastly larger scale across multiple dosage forms and geographies.
• Zydus Lifesciences (Cadila): Major Indian pharmaceutical group with injectable manufacturing across human and animal health segments. Comparable through its injectable formulations portfolio and contract manufacturing services, though at substantially larger scale and broader geographic reach.

Direct peers

• Neon Laboratories: India-based injectable-focused pharmaceutical manufacturer with a domestic and export portfolio of sterile small-molecule formulations. Most directly comparable to BML in product mix (analgesics, antibiotics, critical care injectables) and scale of operations targeting institutional and contract manufacturing customers.
• Alpa Laboratories: Indian manufacturer of sterile injectable formulations (small and large volume parenterals) with domestic and emerging-market exports. Closely matches BML's product mix, scale, and Indore-style mid-tier Indian injectable manufacturer profile.
• Mercury Laboratories: Indian pharmaceutical manufacturer specializing in sterile injectables and small-volume parenterals. Competes with BML in domestic institutional sales and contract manufacturing, with a similarly diversified product base.
• Lyka Labs: Indian sterile injectables manufacturer with a comparable portfolio of human and veterinary parenteral products. Similar mid-tier scale, GMP manufacturing footprint, and B2B distribution to hospitals, institutions, and export markets, making it a closely matched Indian peer.
• Bharat Serums and Vaccines: Indian specialty injectables and biologicals manufacturer (now part of Mankind Pharma) operating in critical care, gynecology, and veterinary segments. Highly comparable to BML's critical-care and veterinary injectable portfolio, though larger and more biologics-focused.

Regional players

• TTK Healthcare: Indian healthcare group with pharmaceutical manufacturing operations including injectables, animal health, and consumer products. Comparable through its animal-health injectables and India-focused manufacturing model, though it operates at larger scale and with broader diversification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/biomedicalab
• Instagraminstagram.com/biomedicalab

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio Medica Laboratories